Biotech · Private company
HighTide Therapeutics (Hong Kong) Limited
Track this companyFree. Adds HighTide Therapeutics (Hong Kong) Limited to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- HTD1801Phase 2 · Fatty Liver, NonalcoholicClinicalTrials.gov · fetched Nov 12, 2026
- HTD1801Phase 2 · Nonalcoholic Steatohepatitis (NASH)ClinicalTrials.gov · fetched Nov 12, 2026
- HTD1801Phase 2 · Primary Sclerosing Cholangitis (PSC)ClinicalTrials.gov · fetched Nov 12, 2026
- HTD1801 (BUDCA)Phase 2 · Primary Biliary CholangitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-DiabetesPHASE2 · COMPLETED · started Dec 27, 2022ClinicalTrials.gov NCT05623189 · fetched Nov 12, 2026
- Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary CholangitisPHASE2 · COMPLETED · started May 27, 2021ClinicalTrials.gov NCT04604652 · fetched Nov 12, 2026
- A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)PHASE2 · COMPLETED · started Nov 26, 2018ClinicalTrials.gov NCT03656744 · fetched Nov 12, 2026
- A POC and Dose-Ranging Study of HTD1801 in PSC PatientsPHASE2 · COMPLETED · started Feb 9, 2018ClinicalTrials.gov NCT03333928 · fetched Nov 12, 2026